HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin-Town Wang Selected Research

Pyogenic Liver Abscess

2/2022Structural and biological insights into Klebsiella pneumoniae surface polysaccharide degradation by a bacteriophage K1 lyase: implications for clinical use.
12/2014Identification of an immuno-dominant protein from Klebsiella pneumoniae strains causing pyogenic liver abscess: implication in serodiagnosis.
1/2014D-galactan II is an immunodominant antigen in O1 lipopolysaccharide and affects virulence in Klebsiella pneumoniae: implication in vaccine design.
1/2012Lipopolysaccharide O1 antigen contributes to the virulence in Klebsiella pneumoniae causing pyogenic liver abscess.
1/2011Functions of some capsular polysaccharide biosynthetic genes in Klebsiella pneumoniae NTUH K-2044.
6/2008Serum-induced iron-acquisition systems and TonB contribute to virulence in Klebsiella pneumoniae causing primary pyogenic liver abscess.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin-Town Wang Research Topics

Disease

22Infections
02/2022 - 12/2002
8Liver Abscess
12/2020 - 07/2004
6Pyogenic Liver Abscess
02/2022 - 06/2008
4Sepsis (Septicemia)
02/2022 - 04/2005
4Neoplasms (Cancer)
01/2022 - 10/2006
3Carcinogenesis
10/2021 - 06/2003
3Pneumonia (Pneumonitis)
12/2020 - 04/2008
2Cross Infection (Nosocomial Infection)
02/2022 - 01/2022
2Abscess
12/2014 - 12/2011
2Endophthalmitis (Ophthalmia)
08/2014 - 08/2011
2Inflammation (Inflammations)
02/2012 - 10/2006
2Adenocarcinoma
10/2006 - 06/2003
1Hepatocellular Carcinoma (Hepatoma)
10/2021
1Neoplasm Metastasis (Metastasis)
10/2021
1Non-alcoholic Fatty Liver Disease
01/2017
1Metabolic Diseases (Metabolic Disease)
01/2017
1Obesity
01/2017
1Virus Diseases (Viral Diseases)
01/2017
1Endotoxemia
01/2017
1Chronic Hepatitis C
01/2017
1Endocarditis
07/2015
1Common Variable Immunodeficiency
09/2014
1Hypersensitivity (Allergy)
11/2013
1Bacteremia
01/2012
1Eye Infections
08/2011
1Peritonitis
12/2009
1Stomach Neoplasms (Stomach Cancer)
04/2008
1Community-Acquired Infections
01/2006
1Gastritis
06/2003
1Esophagitis
05/2003
1Heartburn (Pyrosis)
05/2003
1Transfusion Reaction
12/2002

Drug/Important Bio-Agent (IBA)

6Polysaccharides (Glycans)IBA
02/2022 - 12/2009
6Capsules (Microcapsules)IBA
01/2019 - 08/2011
5Carbapenems (Carbapenem Antibiotics)IBA
02/2022 - 05/2015
5VaccinesIBA
02/2022 - 01/2012
5Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 01/2013
3LipopolysaccharidesIBA
12/2020 - 01/2012
3Proteins (Proteins, Gene)FDA Link
01/2017 - 04/2008
3RNA (Ribonucleic Acid)IBA
04/2008 - 07/2004
2OligosaccharidesIBA
02/2022 - 12/2020
2InterferonsIBA
10/2021 - 01/2017
2EnzymesIBA
10/2021 - 12/2014
2CytokinesIBA
10/2021 - 06/2011
2AntigensIBA
12/2020 - 01/2012
2Virulence Factors (Pathogenicity Factors)IBA
12/2020 - 07/2015
2Colistin (Coly-Mycin)FDA Link
01/2018 - 05/2015
2capsular-polysaccharide galactohydrolaseIBA
01/2017 - 02/2015
2Toll-Like Receptor 4IBA
11/2013 - 06/2011
2Tyrosine (L-Tyrosine)FDA Link
10/2006 - 06/2003
2DNA (Deoxyribonucleic Acid)IBA
01/2006 - 12/2002
1GlycoconjugatesIBA
02/2022
1Free RadicalsIBA
01/2022
1Dual OxidasesIBA
01/2022
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2022
1LactamsIBA
01/2022
1CateninsIBA
10/2021
1Heme (Haem)IBA
10/2021
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
10/2021
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
10/2021
1Conjugate VaccinesIBA
12/2020
1potassium azideIBA
01/2019
1Antimicrobial PeptidesIBA
01/2019
1lipopolysaccharide-binding proteinIBA
01/2017
1Alanine Transaminase (SGPT)IBA
01/2017
1Hemoglobins (Hemoglobin)IBA
01/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1beta-lactamase CMY-2IBA
08/2015
1AntibodiesIBA
12/2014
1Immunoglobulins (Immunoglobulin)IBA
09/2014
1Intravenous Immunoglobulins (IVIG)FDA Link
09/2014
1Immunoglobulin M (IgM)IBA
09/2014
1Retinaldehyde (Retinal)IBA
08/2014
1galactan FIBA
01/2014
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2013
1Bile Acids and Salts (Bile Acids)IBA
11/2013
1Lipoproteins (Lipoprotein)IBA
11/2013
1Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA
11/2013
1OMPA outer membrane proteinsIBA
11/2013
1Peptidoglycan (Murein)IBA
11/2013
1Levofloxacin (Levaquin)FDA Link
10/2009
1IronIBA
06/2008
1ZincIBA
04/2008
1Interleukin-8 (Interleukin 8)IBA
04/2008
1Annexin A4IBA
04/2008
1Metalloproteases (Metalloproteinases)IBA
04/2008
1ElementsIBA
01/2008
1Helicobacter pylori cagA proteinIBA
10/2006
1beta-Lactamases (beta-Lactamase)IBA
01/2006
1Messenger RNA (mRNA)IBA
04/2005
1AllantoinIBA
07/2004
1A-Form DNA (A-DNA)IBA
07/2004
1Indicators and Reagents (Reagents)IBA
05/2003
1AcidsIBA
05/2003
1N-acetyltalosaminuronic acid (NAT)IBA
12/2002
1Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2002

Therapy/Procedure

2Therapeutics
01/2019 - 02/2015
1Intravitreal Injections
08/2014
1Kidney Transplantation
12/2011
1Blood Transfusion (Blood Transfusions)
12/2002